Social networks
38,584Activities
Technologies
Entity types
Location
Windrush Court, Watlington Rd, Oxford OX4 6LT, UK
Oxford
United Kingdom
Employees
Scale: 501-1000
Estimated: 759
Engaged corporates
7Added in Motherbase
2 years, 3 months agoA quality and innovation-led CDMO in cell and gene therapy
OXB (LSE: OXB) is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.
One of the original pioneers in cell and gene therapy, the Company has more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies. The Company collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica's world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.
OXB offers a vast number of unique technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta system), dual plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.
Gene therapy, Immunotherapy, Viral vector GMP manufacturing, and Cell and gene therapy
A life saving cell and gene therapy group
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Ville et Eurométropole de Strasbourg National and local authorities, Government Administration, French metropolis | Ville et Eurométropole de Strasbourg National and local authorities, Government Administration, French metropolis | Other 1 Jul 2024 | | |
BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | BioValley France Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 11 Jul 2024 | | |
Oxford University Innovation Research, Financial Services | Oxford University Innovation Research, Financial Services | Other 22 May 2024 | | |
IP Group plc Financial Services | IP Group plc Financial Services | Other 30 Jun 2023 | | |
Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 26 Jul 2022 | | |
Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Not capitalistic Partnership Not event 30 Jun 2023 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 30 Jun 2022 | |